BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
4.700
-0.180 (-3.69%)
Jul 11, 2025, 4:00 PM - Market closed

BioLineRx Stock Forecast

Stock Price Forecast

The 2 analysts that cover BioLineRx stock have a consensus rating of "Strong Buy" and an average price target of $19, which forecasts a 304.26% increase in the stock price over the next year. The lowest target is $12 and the highest is $26.

Price Target: $19 (+304.26%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $12 $19 $26 $26
Change +155.32% +304.26% +453.19% +453.19%

Analyst Ratings

The average analyst rating for BioLineRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Feb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy 221222
Buy 000000
Hold 001000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$26
Strong Buy Reiterates $26 +453.19% Jun 17, 2025
Jones Trading
Jones Trading
Strong Buy
Upgrades
$12
Strong Buy Upgrades $12 +155.32% May 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$26
Strong Buy Reiterates $26 +453.19% May 28, 2025
Jones Trading
Jones Trading
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Apr 2, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$9$26
Strong Buy Maintains $9$26 +453.19% Mar 31, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.